Literature DB >> 2311972

Gastric enterochromaffin-like (ECL) cells in hypergastrinaemic duodenal ulcer disease.

M Coupe1, H Rees, C J Springer, A E Bishop, J A Morris, J M Polak, J Calam.   

Abstract

Patients with hypergastrinaemic duodenal ulcer disease were studied to determine whether chronic moderate hypergastrinaemia produces hyperplasia of gastric enterochromaffin-like cells in man. Eight patients had peak postprandial plasma gastrin concentrations greater than 200 pmol/l, which is the 92nd percentile for patients with duodenal ulcer disease in this laboratory. The control group was eight patients with duodenal ulcers whose peak postprandial gastrin concentrations were less than 200 pmol/l. Basal and peak postprandial plasma gastrin concentrations were 107 (37) and 306 (66) pmol/l (mean (SEM] respectively in the hypergastrinaemic patients compared with 26 (4) and 137 (14) pmol/l respectively in the controls. There was no significant difference in the density of gastrin enterochromaffin-like cells between the two groups. The number of enterochromaffin-like cells per high power field was 53 (8) in the hypergastrinaemic patients compared with 50 (8) in the controls. We conclude that chronic moderate hypergastrinaemia does not produce hyperplasia of enterochromaffin-like cells in man. Our hypergastrinaemic group had plasma gastrin concentrations similar to, or greater than those reported during treatment with drugs such as omeprazole and histamine H2 receptor blockers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311972      PMCID: PMC1378368          DOI: 10.1136/gut.31.2.144

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis.

Authors:  C Bordi; W Creutzfeldt; R Håkanson; E Solcia; F Sundler
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

2.  Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome.

Authors:  C Bordi; G Cocconi; R Togni; P Vezzadini; G Missale
Journal:  Arch Pathol       Date:  1974-10

3.  Radioimmunoassay of gastrin.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1970-01       Impact factor: 22.682

Review 4.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?

Authors:  J Penston; K G Wormsley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

5.  Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.

Authors:  L Bardram; P Thomsen; F Stadil
Journal:  Digestion       Date:  1986       Impact factor: 3.216

6.  Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells.

Authors:  W Creutzfeldt; F Stöckmann; J M Conlon; U R Fölsch; G Bonatz; M Wülfrath
Journal:  Digestion       Date:  1986       Impact factor: 3.216

7.  Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin.

Authors:  L I Larsson; J F Rehfeld; R Stockbrügger; G Blohme; I M Schöön; G Lundqvist; L G Kindblom; J Säve-Söderberg; L Grimelius; L Olbe
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

8.  Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.

Authors:  R Lamberts; W Creutzfeldt; F Stöckmann; U Jacubaschke; S Maas; G Brunner
Journal:  Digestion       Date:  1988       Impact factor: 3.216

9.  Diffuse enterochromaffin-like (ECL) cell hyperplasia and multiple gastric carcinoids: a complication of pernicious anaemia.

Authors:  J R Hodges; P Isaacson; R Wright
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

10.  Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment.

Authors:  M Mignon; T Lehy; A Bonnefond; P Ruszniewski; D Labeille; S Bonfils
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

View more
  3 in total

1.  Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.

Authors:  Melanie L Richards; Paul Gauger; Norman W Thompson; Thomas J Giordano
Journal:  World J Surg       Date:  2004-06-16       Impact factor: 3.352

Review 2.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 3.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.